Literature DB >> 4733727

The 5-hydroxytryptamine-like actions of 5,6-dihydroxytryptamine.

F Barzaghi, H R Baumgartner, M Carruba, P Mantegazza, A Pletscher.   

Abstract

1. With isolated preparations of rat stomach fundus as well as of duodenum and ileum of rats and guinea-pigs, 5,6-dihydroxytryptamine and 5,6-diacetoxytryptamine caused a contraction which was antagonized by methysergide and lysergic acid diethylamide (LSD), but not by atropine. Pretreatment of the animals with reserpine did not decrease the effect of the two indoleamines on the isolated ileum and duodenum.2. In anaesthetized guinea-pigs, 5,6-dihydroxytryptamine and its diacetyl derivative caused bronchoconstriction which was antagonized by methysergide, but not modified by pretreating the animals with reserpine.3. In anaesthetized cats, 5,6-dihydroxytryptamine had, in general, a hypotensive effect which was reversed by hexamethonium.4. 5,6-Dihydroxytryptamine also caused aggregation of isolated rabbit and human platelets and inhibited the platelet aggregation induced by 5-hydroxytryptamine (5-HT) plus adrenaline.5. The pattern of action of 5,6-hydroxytryptamine and 5,6-diacetoxytryptamine was qualitatively the same as that of 5-HT, but the potency of the compounds decreased in the order 5-HT, 5,6-dihydroxytryptamine, 5,6-diacetoxytryptamine both in vitro and in vivo.6. It is concluded that 5,6-dihydroxytryptamine and its diacetyl derivative stimulate postsynaptic 5-HT receptors, but that their effect is weaker than that of 5-HT.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4733727      PMCID: PMC1776181          DOI: 10.1111/j.1476-5381.1973.tb06910.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat.

Authors:  H G Baumgarten; K D Evetts; R B Holman; L L Iversen; M Vogt; G Wilson
Journal:  J Neurochem       Date:  1972-06       Impact factor: 5.372

2.  An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine.

Authors:  J P Tranzer; H Thoenen
Journal:  Experientia       Date:  1968-02-15

3.  Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.

Authors:  H Thoenen; J P Tranzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

4.  Chemically induced degeneration of indoleamine-containing nerve terminals in rat brain.

Authors:  H G Baumgarten; L Lachenmayer
Journal:  Brain Res       Date:  1972-03-10       Impact factor: 3.252

5.  Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine.

Authors:  H G Baumgarten; A Björklund; L Lachenmayer; A Nobin; U Stenevi
Journal:  Acta Physiol Scand Suppl       Date:  1971

6.  Effects of 5-hydroxytryptamine on platelet aggregation.

Authors:  H R Baumgartner; G V Born
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

7.  Improved apparatus for measurement of guinea pig lung-overflow.

Authors:  M E Resethale; A Dervinis
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-03

8.  5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.

Authors:  H R Baumgartner
Journal:  J Physiol       Date:  1969-04       Impact factor: 5.182

9.  The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets.

Authors:  H R Baumgartner; G V Born
Journal:  J Physiol       Date:  1969-04       Impact factor: 5.182

10.  Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.

Authors:  G V Born; K Juengjaroen; F Michal
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739

View more
  1 in total

1.  Evaluation of the cytotoxicity of dihydroxytryptamines and 5-hydroxytryptamine antagonists as cytotoxic agents in dimethylhydrazine-induced adenocarcinomata.

Authors:  P J Tutton; D H Barkla
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.